About Werfen
Powering Patient Care
In everything we do, we use our passion and long-term vision to develop meaningful innovations that truly enhance patient care and help create healthier societies worldwide.
Immucor, Inc. is now part of Werfen.
On March 15, 2023 Werfen completed the acquisition of Immucor, Inc., a privately held, US-based company, in the in vitro diagnostics sector, with a solid global presence in the Transfusion and Transplant markets.
Our business lines:
Hemostasis
Our Hemostasis product line is comprised of in vitro diagnostic systems, reagents, information management and service, used to diagnose and guide treatment of thrombotic and bleeding disorders. Ultimately, our solutions improve the quality of patient care, lower costs, and assure regulatory compliance in the clinical laboratory.
Acute Care Diagnostics
Integrated and comprehensive whole blood testing product line helps clinicians and laboratorians achieve better outcomes, lower costs, assure regulatory compliance and save time in hospital acute care settings. From cardiovascular operating rooms and catheterization labs, to intensive care units and emergency departments, our Acute Care Diagnostic solutions address today's healthcare challenges by improving efficiency and enhancing patient care.
Transfusion
Offering the broadest range of manual and automated solutions, our Transfusion portfolio delivers results accurately, efficiently and productively. A comprehensive line of serology reagents, fully automated instrumentation, industry-leading data management software and molecular products, help ensure donor-recipient compatibility for those in need of a lifesaving blood transfusion.
Autoimmunity
Through a dedicated focus on autoimmune in vitro diagnostics and lab automation, we anticipate the needs of the world's most demanding laboratories and clinics. Our highly accurate reagents and automated systems are designed to serve labs of all sizes, and they help improve the way patients with autoimmune diseases are diagnosed, monitored, and treated around the world.
Transplant
Featuring molecular and antibody-based assays and software for specialized HLA testing, our Transplant products are used to determine pretransplant compatibility between donors and recipients, and for post-transplant monitoring. By providing high-quality assays, accurate test results, and innovative tools, we can help change the practice of transplant medicine.
Original Equipment Manufacturing (OEM)
Our Technology Center in Barcelona has consolidated experience in research, development and manufacturing of customized assays and biomaterials.
We have significantly contributed to hemostasis and autoimmunity growth, while offering end-to-end solutions for the IVD industry with the most innovative capabilities to enhance competitiveness and time-to-market.
Other Areas of Expertise:
Clinical Chemistry
Complete solutions for the chemistry and pharma-toxicology lab community
MORE INFORMATIONClinical Chemistry
Infusion Therapy
Medical Devices & Scientific Instrumentation
Distribution of proprietary and third-party medical devices and scientific instrumentation.
MORE INFORMATIONMedical Devices & Scientific Instrumentation
"We are fortunate to have best-in-class products and the resources needed to succeed. We are focused on capturing the full value of our portfolio to power patient care and are committed to representing our Values in all that we do."
Bill Crandell
Vice President Commercial Operations, North America.
CAREERS
Make an impact with Werfen
We recognize that each employee is essential to our success. That’s why we’ve built an environment that nurtures, supports and rewards the unique contributions of every individual.
What's happening
News
Something new is always happening in our world, keep up to date with news
September 7, 2023
Werfen launches We Venture Capital to invest in disruptive technologies that will shape the future of diagnostics.
May 26, 2023 - Barcelona, Spain
Werfen successfully completes a new 5-year bond issue for €500 million
March 15, 2023 - Barcelona, Spain
Werfen completes acquisition of Immucor, Inc., expanding leadership in Specialized Diagnostics